MUMBAI, India, April 11 -- Intellectual Property India has published a patent application (202517026996 A) filed by Hanmi Pharm. Co. Ltd., Gyeonggi, Republic of Korea, on March 24, for 'novel tricyclic heterocyclic carbaldehyde compound and pharmaceutical composition, containing same, for ire1a inhibition.'
Inventor(s) include Kim, Ji Sook; Jung, Seung Hyun; Kim, Min Jeong; Park, Won Gi; Choi, Jae Yul; and Ahn, Young Gil.
The application for the patent was published on April 11, under issue no. 15/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to a novel tricyclic heterocyclic carbaldehyde compound and a pharmaceutical composition, containing same, for IRE1a inhibition and, mor...